| Literature DB >> 35570302 |
Elsayed Mohamed Selim Ali1, Tarek Abdelsamad El-Hewala1, Amr Mohamed Eladawy1, Reda Ali Sheta2.
Abstract
PURPOSE: We assessed the efficacy of minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF) in patients with low-grade isthmic spondylolisthesis.Entities:
Keywords: Isthmic spondylolisthesis; Minimal invasive; Spinopelvic harmony; Spondylolysis
Mesh:
Year: 2022 PMID: 35570302 PMCID: PMC9107691 DOI: 10.1186/s13018-022-03144-y
Source DB: PubMed Journal: J Orthop Surg Res ISSN: 1749-799X Impact factor: 2.677
Fig. 1a Preoperative long-standing X-ray with spinopelvic parameters measurements, b preoperative MRI showing L4–5 isthmic spondylolisthesis, c postoperative long-standing X-ray with full correction and spinopelvic parameters measurements, and d postoperative follow-up CT at 1 year showing well union
Patient demographics and operative data among the operated patients (n = 24)
| Patient demographics | |
|---|---|
| n = 24 | |
| Male | 4 (16.7%) |
| Female | 20 (83.3%) |
| Mean ± SD | 40.42 ± 4.65 |
| Median (range) | 42 (32–47) |
| Mean ± SD | 28.12 ± 7.82 |
| Median (range) | 29 (19–44) |
| Comorbidity | |
| Absent | 21 (87.5%) |
| Present | 3 (12.5%) |
| Smoker | 1 (4.2%) |
| Non-smoker | 23 (95.8%) |
| Mean ± SD | 19.42 ± 6.26 |
| Median (range) | 16 (13–24) |
| L5–S1 | 17 (70.8%) |
| L4–L5 | 7 (29.2%) |
| Grade 2 | 9 (37.5%) |
| Grade 3 | 15 (62.5%) |
| Operative data | |
| Mean ± SD | 3.79 ± 0.83 |
| Median (range) | 4 (3–5) |
| Mean ± SD | 56.45 ± 14.63 |
| Median (range) | 52.50 (40–90) |
| Mean ± SD | 110.20 ± 13.39 |
| Median (range) | 110 (90–135) |
Functional outcome measures and post hoc test results
| Baseline | Postoperative | Test* | ||||
|---|---|---|---|---|---|---|
| 6 weeks | 6 months | Final | ||||
| Mean ± SD | 8.42 ± 0.58 | 3.58 ± 0.65 | 2.17 ± 0.38 | 1.79 ± 0.88 | 62.074 | < 0.001 (HS) |
| Median (range) | 8 (7–9) | 3.5 (3–5) | 2 (2–3) | 1.5 (1–3) | ||
| Mean ± SD | 7.46 ± 0.98 | 3.33 ± 0.48 | 1.25 ± 0.44 | 1.00 ± 1.59 | 66.792 | < 0.001 (HS) |
| Median (range) | 7 (6–9) | 3 (3–4) | 1 (1–2) | 1 (0–8) | ||
| Mean ± SD | 52.21 ± 6.79 | 17.54 ± 1.25 | 14.04 ± 2.35 | 15.71 ± 9.95 | 59.484 | < 0.001 (HS) |
| Median (range) | 51 (42–63) | 18 (15–19) | 14 (10–19) | 14.5 (10–61) | ||
*Friedman’s test was used, ‡ Wilcoxon signed-rank test, p < 0.05 is significant and Sig.: Significance
Radiological outcome measures
| Baseline | Postoperative | Test | ||||
|---|---|---|---|---|---|---|
| 6 weeks | 6 months | final | ||||
| Mean ± SD | 61.83 ± 8.77 | 61.78 ± 8.88 | 61.61 ± 8.90 | 61.61 ± 8.99 | 1.654* | 0.196 |
| Median (range) | 62.15 (50.2–77.9) | 62.15 (50.3–78) | 62.15 (49.7–78.1) | 62.15 (49–78.1) | ||
| Mean ± SD | 21.07 ± 8.74 | 26.42 ± 5.99 | 21.12 ± 5.20 | 19.84 ± 4.20 | 36.620‡ | < 0.001 (HS) |
| Median (range) | 20.6 (8–32.9) | 28.35 (15–35) | 19.25 (13–31.5) | 19.45 (12.3–27) | ||
| Mean ± SD | 40.72 ± 7.03 | 35.62 ± 6.01 | 40.69 ± 5.73 | 41.98 ± 6.19 | 22.410* | < 0.001 (HS) |
| Median (range) | 40.70 (25.9–54) | 34.90 (23–45.9) | 40.90 (32.2–50) | 42.6 (32.1–52.9) | ||
| Mean ± SD | 57.23 ± 9.23 | 54.87 ± 6.88 | 57.78 ± 7.20 | 57.94 ± 6.83 | 7.213‡ | 0.047 (S) |
| Median (range) | 56.35 (40–73) | 57.15 (42–65.1) | 58 (44.9–68.4) | 59 (47.4–68.9) | ||
| Mean ± SD | 5.13 ± 3.97 | 5.98 ± 4.71 | 6.48 ± 5.58 | 53.27‡ | < 0.001 (HS) | |
| Median (range) | 23.5 (5–42) | 4 (1–16) | 4.5 (1.8–18) | 4.5 (1.8–23) | ||
| Mean ± SD | 10.33 ± 7.48 | 7.67 ± 4.90 | 6.31 ± 2.85 | 6.21 ± 2.85 | 4.513‡ | 0.211 |
| Median (range) | 8.55 (0–23.7) | 7.20 (0.1–18) | 7.30 (1–9.9) | 7.10 (0.1–9.9) | ||
| Mean ± SD | 30.10 ± 8.02 | 27.41 ± 7.21 | 27.88 ± 7.29 | 27.65 ± 6.56 | 12.443‡ | 0.006 (S) |
| Median (range) | 30.80 (15.6–41) | 28.95 (13.7–34.2) | 28.80 (15.7–41.1) | 27.50 (17.2–38.6) | ||
| Mean ± SD | 35.07 ± 6.47 | 37.55 ± 5.09 | 37.92 ± 4.2 | 38.88 ± 4.24 | 12.602* | < 0.001 (HS) |
| Median (range) | 34.15 (23.8–45) | 38 (27.9–44.5) | 38.50 (32–45) | 39.15 (31.2–45.2) | ||
| Mean ± SD | 16.30 ± 6.52 | 22.23 ± 7.10 | 21.12 ± 6.50 | 20.70 ± 6.49 | 49.034‡ | < 0.001(HS) |
| Median (range) | 14.40 (4.2–30) | 19 (14.8–38.9) | 19.40 (13.9–38) | 19.10 (13.9–37) | ||
*Repeated measures ANOVA test, ‡ Friedman's test
S: Significant(P < 0.05); HS: Highly significant (P < 0.01)
The comparison according to the mismatch between the PI and LL
| Parameters | Mismatch | Test§ | ||
|---|---|---|---|---|
| Normal (N = 14) | Abnormal (N = 10) | (Sig.) | ||
| Mean ± SD | 6.71 ± 1.20 | 6.50 ± 1.17 | − 0.426 | 0.670 |
| Median (range) | 7 (5–8) | 6 (5–8) | ||
| Mean ± SD | 6.28 ± 1.89 | 6.70 ± 0.82 | − 0.333 | 0.739 |
| Median (range) | 6 (1–8) | 7 (5–8) | ||
| Mean ± SD | 32.64 ± 11.55 | 41.90 ± 8.69 | − 2.056 | 0.040 (S) |
| Median (range) | 36.50 (− 3 to 47) | 45.50 (27–51) | ||
| Mean ± SD | − 0.34 ± 0.86 | − 0.03 ± 0.26 | − 0.709 | 0.478 |
| Median (range) | 0 (− 2.80 to 0.60) | 0 (- 0.40 to 0.30) | ||
| Mean ± SD | 0.88 ± 4.30 | − 4.19 ± 6.43 | − 2.288 | 0.022 (S) |
| Median (range) | 1.20 (− 5.10 to 5.70) | − 5.90 (− 10.70 to 9) | ||
| Mean ± SD | − 1.05 ± 4.46 | 4.49 ± 6.49 | − 2.317 | 0.020 (S) |
| Median (range) | − 1.15 (− 6.50 to 5.10) | 7.10 (− 9 to 10.80) | ||
| Mean ± SD | − 3.60 ± 5.05 | 6.73 ± 9.93 | − 2.698 | 0.007(S) |
| Median (range) | − 2.25 (− 12.80 to 4) | 9.80 (− 13 to 14.60) | ||
| Mean ± SD | − 2.17 ± 5.20 | − 2.82 ± 8.10 | − 0.293 | 0.769 |
| Median (range) | − 3.15 (− 11.20 to 7) | − 5.05 (− 12.30 to 7.80) | ||
| Mean ± SD | 2.75 ± 4.19 | 5.31 ± 4.04 | − 1.642 | 0.101 |
| Median (range) | 2.95 (− 5 to 10.20) | 7.90 (− 1.60 to 9) | ||
| Mean ± SD | 2.34 ± 2.99 | 7.26 ± 3.44 | − 3.165 | 0.002 (S) |
| Median (range) | 3.15 (− 6.20 to 5.80) | 6.55 (0.80–12.20) | ||
Δ VAS: VAS baseline–VAS final, Δ ODI: ODI baseline–ODI final, Δ PI: PI at final–PI baseline, Δ PT: PT final–PT baseline, Δ SS: SS final–SS baseline, Δ LL: LL final–LL baseline, Δ L1–L4: L1–L4 final–L1–L4 baseline, Δ L4–S1: L4–S1 final–L4–S1 baseline, Δ SL: SL final–SL baseline, § Mann–Whitney U test., p < 0.05 is significant and Sig.: Significance
Comparison according to the SDSG grade at 12 months
| Parameters | SDSG | Test§ | ||
|---|---|---|---|---|
| SDSG 2 ( | SDSG 3 ( | (Sig.) | ||
| Mean ± SD | 1.44 ± 0.72 | 2 ± 0.92 | − 1.462 | 0.144 |
| Median (range) | 1 (1–3) | 2 (1–3) | ||
| Mean ± SD | 0.77 ± 0.44 | 1.13 ± 1.99 | − 0.341 | 0.733 |
| Median (range) | 1 (0–1) | 1 (0–8) | ||
| Mean ± SD | 13.78 ± 2.108 | 16.87 ± 12.495 | − 0.272 | 0.786 |
| Median (range) | 14 (11–17) | 15 (10–61) | ||
| Mean ± SD | 17.02 ± 2.99 | 21.53 ± 3.95 | − 2.534 | 0.011 |
| Median (range) | 16 (12.30–22.20) | 21.90 (14–27) | (S) | |
| Mean ± SD | 35.4778 ± 2.28844 | 45.8733 ± 4.06966 | − 8.006 | < 0.001 |
| Median (range) | 35.8(32.1–40) | 45 (39.7–52.9) | (HS) | |
| Mean ± SD | 52.46 ± 4.95 | 61.22 ± 5.64 | − 3.139 | 0.002 |
| Median (range) | 50 (47.40–59) | 60 (50.80–68.90) | (S) | |
| Mean ± SD | 5.22 ± 3.31 | 6.80 ± 2.76 | − 1.283 | 0.2 |
| Median (range) | 4.60 (1.60–9.50) | 7.20 (0.10–9.90) | ||
| Mean ± SD | 23 ± 6.09 | 30.4 ± 5.32 | − 2.419 | 0.016 |
| Median (range) | 20 (17– 32.2) | 29.8 (22.3–38.6) | (S) | |
| Mean ± SD | 37.44 ± 3.19 | 39.74 ± 4.64 | − 1.404 | 0.16 |
| Median (range) | 38.10 (33.70–43.30) | 41.90 (31.20–45.20) | ||
| Mean ± SD | 20.62 ± 3.01 | 20.74 ± 8 | − 1.343 | 0.179 |
| Median (range) | 21.90 (14.60–23.60) | 17.30 (13.90–37) | ||
§ Mann–Whitney U test, p < 0.05 is significant. Sig.: Significance